Barriers to the diagnosis and treatment of migraine: Effects of sex, income, and headache features

Headache

Volumn 53, Issue 1, 2013, Pages 81-92

  Lipton, Richard B ^a,b   Serrano, Daniel ^c   Holland, Starr ^d   Fanning, Kristina M ^c   Reed, Michael L ^c   Buse, Dawn C ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c VEDANTA RESEARCH   (United States)

^d Armstrong State University   (United States)

Author keywords

acute medication; barrier to care; episodic migraine; headache; headache related disability; migraine

Indexed keywords

ADULT; ANALGESIA; ARTICLE; CONSULTATION; DISEASE SEVERITY; EPISODIC MIGRAINE; FEMALE; HEADACHE; HEALTH CARE UTILIZATION; HUMAN; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIGRAINE DISABILITY ASSESSMENT SCALE; PRIORITY JOURNAL; RATING SCALE; SEX DIFFERENCE;

ADULT; AGED; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84872099492     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02265.x     Document Type: Article

References (20)

1. Stewart WF, Lipton RB, Celentano DD, Reed ML,. Prevalence of migraine headache in the United States: Relation to age, income, race, and other sociodemographic factors. JAMA. 1992; 267: 64-69.
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M,. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001; 41: 646-657.
3. Ferrari MD,. The economic burden of migraine to society. Pharmacoeconomics. 1998; 13: 667-676.
4. Stewart WF, Lipton RB, Simon D,. Work-related disability: Results from the American Migraine Study. Cephalalgia. 1996; 16: 231-238.
5. Michel P, Dartigues JF, Lindousli A, Henry P,. Loss of productivity and quality of life in migraineurs among French workers: Results from the GAZEL cohort. Headache. 1997; 37: 71-78.
6. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ,. Impact of migraine and tension-type headache on life-style, consulting behavior, and medication use: A Canadian population survey. Can J Neurol Sci. 1993; 20: 131-137.
7. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF,. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007; 68: 343-349.
8. Buse DC, Bigal ME, Serrano D, Golden W, Lipton RB,. Triptan use patterns among migraine sufferers: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Cephalalgia. 2009; 29: 11.
9. Bigal ME, Borucho S, Serrano D, Lipton RB,. The acute treatment of episodic and chronic migraine in the USA. Cephalalgia. 2009; 29: 891-897.
10. Silberstein SD,. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 55: 754-762.
11. Pryse-Phillips WE, Dodick DW, Edmeads JG, et al,. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ. 1997; 156: 1273-1287.
12. Lipton RB, Amatniek JC, Ferrari MD, Gross M,. Migraine: Identifying and removing barriers to care. Neurology. 1994; 44 (Suppl. 4): S63-S68.
13. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24: 9-160.
14. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman J,. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000; 88: 41-52.
15. Lipton RB, Stewart WF, Simon D,. Medical consultation for migraine: Results from the American Migraine Study. Headache. 1998; 38: 87-96.
16. Spitzer RL, Kroenke K, Williams JBW, for the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. JAMA. 1999; 282: 1737-1744.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press; 2000.
18. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB,. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention Study. Headache. 2007; 47: 355-363.
19. Bigal ME, Buse DC, Chen YT, et al,. Rates and predictors of starting a triptan: Results from the American Migraine Prevalence and Prevention Study. Headache. 2010; 50: 1440-1448.
20. Katic̈ BJ, Rajagopalan S, Ho TW, Chen YT, Hu XH,. Triptan persistency among newly initiated users in a pharmacy claims database. Cephalalgia. 2011; 31: 488-500.